Serotype distribution of Streptococcus pneumoniae causing invasive disease in the Republic of Ireland

I Vickers1, M Fitzgerald, S Murchan

  • 1Epidemiology and Molecular Biology Unit and Irish Meningococcal and Meningitis Reference Laboratory, Children's University Hospital, Dublin, Ireland. imelda.vickers@cuh.ie

Insights

The 7-valent pneumococcal conjugate vaccine (PCV7) reduced invasive pneumococcal disease in Irish infants. Serotype 14 remained common, and a new serotype 6C was identified, impacting vaccine effectiveness.

Area of Science:

  • Microbiology
  • Immunology
  • Public Health

Background:

  • The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into Ireland's routine infant immunization program in September 2008.
  • Invasive pneumococcal disease (IPD) remains a significant public health concern, particularly in young children.

Purpose of the Study:

  • To determine the serotype distribution of Streptococcus pneumoniae isolates causing invasive disease in Ireland before and after PCV7 introduction.
  • To assess the prevalence of the novel serotype 6C and evaluate antibiotic susceptibility patterns.
  • To estimate the potential impact of PCV7 on IPD in children under two years old.

Main Methods:

  • Analysis of 977 S. pneumoniae isolates from invasive disease cases during 2000-2002 and 2007-2008.
  • Serotyping of isolates and specific assessment for serotype 6C.
  • Determination of susceptibility to penicillin and cefotaxime for isolates from 2007-2008.

Main Results:

  • Serotype 14 was the most prevalent serotype in both study periods.
  • Approximately 7.7% of isolates previously identified as serotype 6A were reclassified as the newly described serotype 6C.
  • PCV7's potential to prevent IPD in children under two decreased from 85% (2000-2002) to 74% (2007-2008).
  • Penicillin non-susceptibility was observed in 17% of isolates in 2007-2008.

Conclusions:

  • Ongoing surveillance of pneumococcal serotypes is crucial to monitor the impact of PCV7 and inform future vaccination strategies.
  • The emergence of serotype 6C and shifts in serotype prevalence may affect the long-term effectiveness of current vaccines.
  • The findings highlight the need for updated vaccines with broader serotype coverage to address evolving pneumococcal epidemiology.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...